Covid-19 and Influenza Oral Vaccine Study
Phase 1
Recruiting
- Conditions
- covid19 InfectionInfluenza, Human
- Interventions
- Biological: Covid-19 vaccineBiological: Influenza vaccine
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06355232
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
Autologous Tumour Vaccine Trial
Phase 1
Recruiting
- Conditions
- Solid Tumor
- Interventions
- Biological: Radvax
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT05807035
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
Booster Study of SpikoGen COVID-19 Vaccine
Phase 3
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- Biological: SpikoGen vaccine
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT05542862
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
Phase 3
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- Biological: Advax-CpG55.2 adjuvanted recombinant spike protein
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 39
- Registration Number
- NCT05279456
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
Phase 2
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- Biological: Spikogen/Covax-19
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT05148871
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
Monovalent Recombinant COVID19 Vaccine
Phase 1
Completed
- Conditions
- Coronavirus InfectionCOVID
- Interventions
- Biological: COVID19 vaccineBiological: Saline
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT04453852
- Locations
- 🇦🇺
PARC,, Adelaide, South Australia, Australia
Recombinant H7 Hemagglutinin Influenza Vaccine Trial
Phase 1
Completed
- Conditions
- Influenza, Avian
- Interventions
- Biological: Recombinant influenza hemagglutinin
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT03038776
- Locations
- 🇦🇺
Flinders University, Adelaide, South Australia, Australia
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection
Phase 1
Not yet recruiting
- Conditions
- Chronic Hepatitis b
- Interventions
- Biological: Therapeutic hepatitis B vaccineBiological: Commercial Hepatitis B vaccine
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT03038802
- Locations
- 🇦🇺
ARASMI, Adelaide, South Australia, Australia
A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Phase 1
Completed
- Conditions
- Influenza
- Interventions
- Biological: recombinant influenza hemagglutininBiological: Advax1Biological: Advax2
- First Posted Date
- 2015-01-09
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 270
- Registration Number
- NCT02335164
- Locations
- 🇦🇺
Flinders University, Adelaide, South Australia, Australia
Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine
Phase 1
Completed
- Conditions
- Exposure to Hepatitis B Virus
- Interventions
- Biological: PreS HBsAgDrug: HBsAgBiological: Advax-1(TM)Biological: Advax-2(TM)Biological: AlumBiological: Advax-3(TM)
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Vaxine Pty Ltd
- Target Recruit Count
- 240
- Registration Number
- NCT01951677
- Locations
- 🇦🇺
Flinders Medical Centre, Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath